Authors


Jaclyn Rosenzweig, MD

Latest:

A Case of CNS Nocardia farcinica Presenting as Aphasia in an Immunocompetent Host

Quick recognition is key to early initiation of treatment and long-term survival.


Becky Jayakumar, PharmD

Latest:

Clinical Outcomes of Vancomycin Mono or Combination Therapy with a Beta-Lactam Against MRSA Bacteremia

Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with high mortality.


JACK JACOB, DO

Latest:

The Case of Late Aspergillus Fumigatus Infection of Implantable Cardioverter Defibrillator Leads

Quick action was needed against this very rare cause of fungal endocarditis.


Katherine Lusardi, PharmD, BCPS-AQ ID, BCIDP*

Latest:

Daptomycin Dosing in Obesity: Consideration for a Fixed-Dose Strategy

This In the Literature piece considers a fixed-dose strategy for administering daptomycin in obese patients.


Ricardo A. Camargo, PharmD Candidate

Latest:

Treating Outpatient Cystitis in the Era of Antimicrobial Resistance

What can clinicians do now that increasing resistance has limited oral treatment options for outpatient cystitis?


Kerry Cleveland, MD, FACP, FIDSA, FSHEA

Latest:

Acute Bacterial Skin and Skin Structure Infections: A Modernized Approach

The emergence of hospital- and community-based MRSA and other resistant gram-positive pathogens have made ABSSSI a critical public health challenge.


Elizabeth B. Hirsch, PharmD, RPH, FIDSA

Latest:

What's New In 2024: From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing had its series of meetings to update breakpoints for a variety of classes of antimicrobials.



Laurie Saloman, MS

Latest:

Phase 3 Trial of Bulevirtide Yields Positive Results

For people living with chronic hepatitis D, the latest study results confirm the benefit of injections of this first-in-class entry inhibitor.


PRESS RELEASE

Latest:

Contagion&reg Interviews Pat Smith to Mark Lyme Disease Awareness Month

In recognition of Lyme disease awareness month, Contagion® interviewed Pat Smith, president of Lyme Disease Association, Inc, to better understand current issues surrounding the diagnosis and treatment of Lyme disease.


Samantha Hitchcock

Latest:

C Difficile Infection Is Associated With Higher Mortality Rates in Patients With Cirrhosis

Clostridium difficile infection leads to higher rates of overall mortality among patients with cirrhosis compared to those who do not, according to a new study.


Celeste Caulder, PharmD

Latest:

Antiretroviral Safety in Pregnancy: Focus on Dolutegravir, Integrase Inhibitors, and Neural Tube Defects

There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.


Alexandra M. Hanretty, PharmD*

Latest:

The Continued Search for Optimal Daptomycin Dosing Strategies in VRE Bloodstream Infections

Optimal dosing of daptomycin is unknown, but study results suggest higher doses are required for successful clinical and microbiological outcomes.


ALLISON KOMIRENKO, PHARMD

Latest:

Implications of the 21st Century Cures Act on Antibiotic Drug Development

Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.


Thomas Castles

Latest:

How Does HIV Affect the Brain?

Dr. Shibani Mukerji discusses how HIV affects the brain as part of a symposium at ID Week 2017.


RYAN W. STEVENS, PHARMD, BCIDP, BCPS

Latest:

Exploring Primary Prophylaxis for Invasive Pulmonary Aspergillosis

Invasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.


DENISE CARDO, MD

Latest:

Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report

A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.


Gina Battaglia

Latest:

Diagnosis and Treatment of Chronic Lyme Disease: A Complex Issue

Recognition of chronic Lyme disease and the role of long-term antibiotic treatment for persistent symptoms continue to be controversial among researchers, providers, patients, and advocates.


Laura Genn

Latest:

Effectiveness of Pertussis Vaccine May Wane Over Time, Study Shows

Kaiser Permanente Northern California’s study shows that the pertussis vaccine weakens as time passes after a patient's most recent vaccination.


Jenina Pellegren

Latest:

Pfizer Foundation Donates Millions to Help Combat Zika

The CDC Foundation and the Florida Department of Health have announced that the the Pfizer Foundation has donated millions to improve Zika response efforts.


Christina G. Rivera*, PharmD, BCPS, AAHIV-M

Latest:

Outpatient Antimicrobial Stewardship: Field of Dreams or Land of Opportunity for Pharmacists?

Relevant existing reports, though limited, demonstrated positive outcomes and suggest a promising space for pharmacy practice growth in outpatient antimicrobial stewardship.


KIMBERLY C. CLAEYS, PHARMD, BCPS*+

Latest:

Diagnostic Stewardship: Beyond Managing Bloodstream Infections

Diagnostic stewardship is a novel concept related to modifying the process of ordering, testing, and reporting with the goal of decreasing unnecessary testing and treatment, working upstream and synergistically with antimicrobial stewardship principles.


David A. Schwartz, MD, MS Hyg, FCAP

Latest:

COVID-19, SARS-CoV-2 and Pregnancy: Does the Past Predict the Present?

Preliminary evidence indicates no direct evidence for intrauterine transmission of the SARS-CoV-2 virus from pregnant women with COVID-19 to their infants.


TAYLOR MORRISETTE, PHARMD*+

Latest:

Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?

Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.


Ahmed Babiker, MBBS

Latest:

Intravenous Fosfomycin for Systemic Multidrug-Resistant Infections

Intravenous (IV) fosfomycin offers a novel therapeutic option in the treatment of systemic multi-drug resistant (MDR) infections. Unanswered questions remain regarding its efficacy and specific role in our therapeutic arsenal.


Kyle Massey, PharmD

Latest:

Shoutout to the Stewards: Holiday Edition

Contagion® radio is here to bring joy with every new antibiotic alert!


JOSEPH KOHN, PHARMD

Latest:

Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score

The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.


MelANIE T. MAHONEY, MPH, PHARMD STUDENT

Latest:

What's New From the CLSI Subcommittee on Antimicrobial Susceptibility Testing

Updates include novel and revised breakpoints for azithromycin, polymyxins, daptomycin, and cefiderocol.


Glenn Tillotson, PhD

Latest:

Pan-resistant, Currently Untreatable Gram-Negative Infections Come Closer to Home

The global emergence of antimicrobial resistance among gram-negative species is a major public health concern.


Ravina Kullar, PharmD, MPH, FIDSA*

Latest:

Investigational Treatments for Clostridioides difficile Infection

The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.

© 2024 MJH Life Sciences

All rights reserved.